EA202191373A1 - PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING - Google Patents

PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING

Info

Publication number
EA202191373A1
EA202191373A1 EA202191373A EA202191373A EA202191373A1 EA 202191373 A1 EA202191373 A1 EA 202191373A1 EA 202191373 A EA202191373 A EA 202191373A EA 202191373 A EA202191373 A EA 202191373A EA 202191373 A1 EA202191373 A1 EA 202191373A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
obtaining
amorphous
lamivudine
ritonavir
Prior art date
Application number
EA202191373A
Other languages
Russian (ru)
Inventor
Ацуси Кано
Со Тойонага
Original Assignee
Фуджифилм Корпорэйшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фуджифилм Корпорэйшн filed Critical Фуджифилм Корпорэйшн
Publication of EA202191373A1 publication Critical patent/EA202191373A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Предложены фармацевтическая композиция, содержащая аморфную твердую дисперсию, содержащую аморфные лопинавир и ритонавир и полимер на основе целлюлозы, и ламивудин; и способ получения фармацевтической композиции.What is proposed is a pharmaceutical composition containing an amorphous solid dispersion containing amorphous lopinavir and ritonavir and a cellulose-based polymer, and lamivudine; and a method for preparing a pharmaceutical composition.

EA202191373A 2018-12-14 2019-12-13 PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING EA202191373A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018234691 2018-12-14
PCT/JP2019/049013 WO2020122241A1 (en) 2018-12-14 2019-12-13 Pharmaceutical composition and method for producing same

Publications (1)

Publication Number Publication Date
EA202191373A1 true EA202191373A1 (en) 2021-12-27

Family

ID=71076924

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191373A EA202191373A1 (en) 2018-12-14 2019-12-13 PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING

Country Status (2)

Country Link
EA (1) EA202191373A1 (en)
WO (1) WO2020122241A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014130553A2 (en) * 2013-02-20 2014-08-28 Abbvie Inc. Tablet dosage forms

Also Published As

Publication number Publication date
WO2020122241A1 (en) 2020-06-18

Similar Documents

Publication Publication Date Title
UY37278A (en) ANTI-B7-H3 ANTIBODIES AND DRUG AND ANTIBODY CONJUGATES
WO2018128662A3 (en) Large scale optical phased array
EA201891339A1 (en) AQUEOUS PHARMACEUTICAL PREPARATION THAT CONTAINS ANTIBODY TO PD-L1 AVELUMAB
EA201891087A1 (en) RET INHIBITORS
BR112018075644A2 (en) anti-cd98 antibodies and antibody and drug conjugates
BR112015001768A2 (en) method and device for child mode processing
EA201991715A1 (en) COMPOSITIONS CONTAINING AN ANTIBODY TO PDL1
TWD178161S (en) Iot smart device
BR112016025056A2 (en) use of at least one polypeptide, bispecific antibody, isolated bispecific antibody, her3 / her2 bispecific antibody, host cell, her3 / her2 bispecific antibody production method, immunoconjugate and pharmaceutical formulation
BR112018014705A2 (en) bruton tyrosine kinase inhibitors
BR112018075630A2 (en) anti-cd98 antibodies and antibody drug conjugates
EA201690099A1 (en) SUSTAINABLE LIQUID COMPOSITION CONTAINING AMG-416 (VELCALCETIDE)
BR112017019004A2 (en) light field metadata
BR112019003025A2 (en) data processing method and apparatus
EA201790155A1 (en) LOADING DEVICE FOR GLASS SUBSTRATE
EA201992027A1 (en) WATER COMPOSITION OF ANTIBODIES AGAINST PD-L1
BR112017025427A2 (en) oral pharmaceutical composition
BR112016017609A2 (en) COMPOSITION AND PROCESS
EA201790373A1 (en) METHODS OF OBTAINING MODULATORS OF TOLL-SIMILAR RECEPTORS
BR112016024457A2 (en) isolated antibody, immunoconjugate, antibody use, pharmaceutical formulation, isolated nucleic acid, host cell and method of producing an antibody
EA201792312A1 (en) CONSTRUCTIONS BASED ON KALIHEAMICIN AND METHODS OF THEIR APPLICATION
BR112017028242A2 (en) dynamic portable communication system
EA202191373A1 (en) PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING
EA201700555A1 (en) COMPOSITION OF COPOLYMER PROPYLENE
GB201509514D0 (en) A software application (app) on a computer or mobile device developed for measuring the size of a fish from a photograph. This process is called fishfigure.